Iqvia Holdings (IQV) Operating Expenses (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Operating Expenses came in at $637.0 million in Q2 2026, up 17.74% year-over-year from $541.0 million in Q2 2025, and up 15.19% quarter-over-quarter from $553.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Operating Expenses (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Operating Expenses across 15 years of filings, most recently posting $637.0 million for Q2 2026.
- In Q2 2026, Operating Expenses rose 17.74% year-over-year to $637.0 million; the TTM figure through Jun 2026 stood at $2.2 billion (up 6.69% YoY), while the FY2025 annual figure was $2.3 billion, up 2.54% from the prior year.
- Operating Expenses came in at $637.0 million for Q2 2026 at Iqvia Holdings, up from $553.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $637.0 million in Q2 2026 to a low of $449.0 million in Q4 2024.
- Average Operating Expenses over 5 years is $532.7 million, with a median of $533.0 million recorded in 2023.
- Year-over-year, Operating Expenses retreated 21.64% in 2024 and advanced 17.74% in 2026.
- Over 5 years, Operating Expenses stood at $596.0 million in 2022, then fell by 3.86% to $573.0 million in 2023, then fell by 21.64% to $449.0 million in 2024, then climbed by 9.58% to $492.0 million in 2025, then advanced by 29.47% to $637.0 million in 2026.
- Per Business Quant data, the three most recent Operating Expenses figures were $637.0 million in Q2 2026, $553.0 million in Q1 2026, and $492.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 637.00 Mn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 560.51 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 1.93 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 228.90 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 663.40 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 78.70 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 15.64 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 6.01 Bn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 2.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 637.00 Mn |
| Mar 31, 2026 | 553.00 Mn |
| Dec 31, 2025 | 492.00 Mn |
| Sep 30, 2025 | 534.00 Mn |
| Jun 30, 2025 | 541.00 Mn |
| Mar 31, 2025 | 537.00 Mn |
| Dec 31, 2024 | 449.00 Mn |
| Sep 30, 2024 | 550.00 Mn |
| Jun 30, 2024 | 537.00 Mn |
| Mar 31, 2024 | 523.00 Mn |
| Dec 31, 2023 | 573.00 Mn |
| Sep 30, 2023 | 532.00 Mn |
| Jun 30, 2023 | 502.00 Mn |
| Mar 31, 2023 | 530.00 Mn |
| Dec 31, 2022 | 596.00 Mn |
| Sep 30, 2022 | 521.00 Mn |
| Jun 30, 2022 | 487.00 Mn |
| Mar 31, 2022 | 495.00 Mn |
| Dec 31, 2021 | 547.00 Mn |
| Sep 30, 2021 | 500.00 Mn |